Compare ASMB & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | IBEX |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 448.0M |
| IPO Year | 2010 | 2017 |
| Metric | ASMB | IBEX |
|---|---|---|
| Price | $23.53 | $43.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.20 | $35.00 |
| AVG Volume (30 Days) | ★ 296.9K | 140.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | 32.63 |
| EPS | N/A | ★ 3.13 |
| Revenue | N/A | ★ $644,076,000.00 |
| Revenue This Year | N/A | $14.13 |
| Revenue Next Year | $638.39 | $5.68 |
| P/E Ratio | ★ N/A | $13.88 |
| Revenue Growth | N/A | ★ 15.37 |
| 52 Week Low | $21.80 | $25.94 |
| 52 Week High | $39.71 | $45.28 |
| Indicator | ASMB | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 27.73 | 67.17 |
| Support Level | $21.80 | $27.98 |
| Resistance Level | $30.36 | N/A |
| Average True Range (ATR) | 1.48 | 2.01 |
| MACD | -0.64 | 0.31 |
| Stochastic Oscillator | 3.01 | 86.11 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.